Chavachol Setthaudom

433 total citations
23 papers, 218 citations indexed

About

Chavachol Setthaudom is a scholar working on Infectious Diseases, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Chavachol Setthaudom has authored 23 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 6 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Chavachol Setthaudom's work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (6 papers) and T-cell and B-cell Immunology (4 papers). Chavachol Setthaudom is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (6 papers) and T-cell and B-cell Immunology (4 papers). Chavachol Setthaudom collaborates with scholars based in Thailand and United Kingdom. Chavachol Setthaudom's co-authors include Prapaporn Pisitkun, Pintip Ngamjanyaporn, Jackrapong Bruminhent, Angsana Phuphuakrat, Arkom Nongnuch, Kumthorn Malathum, Sasisopin Kiertiburanakul, Saovanee Leelayoova, Kumutnart Chanprapaph and Mathirut Mungthin and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Allergy and Clinical Immunology.

In The Last Decade

Chavachol Setthaudom

20 papers receiving 216 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chavachol Setthaudom Thailand 10 111 62 42 28 25 23 218
Nathalie Chavarot France 7 100 0.9× 52 0.8× 24 0.6× 27 1.0× 77 3.1× 17 245
Marcela Castro United States 5 134 1.2× 83 1.3× 66 1.6× 10 0.4× 59 2.4× 14 455
Gerrit Ahrenstorf Germany 10 54 0.5× 84 1.4× 14 0.3× 20 0.7× 21 0.8× 20 208
Hamza Sakhi France 7 65 0.6× 34 0.5× 32 0.8× 9 0.3× 9 0.4× 16 151
Nassima Bellal France 7 140 1.3× 63 1.0× 19 0.5× 13 0.5× 45 1.8× 8 338
Noëlle Cognard France 9 262 2.4× 55 0.9× 7 0.2× 59 2.1× 28 1.1× 15 412
Jeremy Anderson Australia 14 77 0.7× 104 1.7× 7 0.2× 13 0.5× 69 2.8× 22 348
Eleonora Tartaglia Italy 9 130 1.2× 52 0.8× 7 0.2× 14 0.5× 37 1.5× 18 253
Michael Cartwright United States 5 52 0.5× 92 1.5× 7 0.2× 8 0.3× 43 1.7× 8 201
Christophe Masset France 8 110 1.0× 13 0.2× 7 0.2× 30 1.1× 19 0.8× 28 184

Countries citing papers authored by Chavachol Setthaudom

Since Specialization
Citations

This map shows the geographic impact of Chavachol Setthaudom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chavachol Setthaudom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chavachol Setthaudom more than expected).

Fields of papers citing papers by Chavachol Setthaudom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chavachol Setthaudom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chavachol Setthaudom. The network helps show where Chavachol Setthaudom may publish in the future.

Co-authorship network of co-authors of Chavachol Setthaudom

This figure shows the co-authorship network connecting the top 25 collaborators of Chavachol Setthaudom. A scholar is included among the top collaborators of Chavachol Setthaudom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chavachol Setthaudom. Chavachol Setthaudom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Suchonwanit, Poonkiat, et al.. (2023). Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients. Frontiers in Immunology. 14. 1138765–1138765. 7 indexed citations
4.
Watcharananan, Siriorn P., Peera Jaru-Ampornpan, Anan Jongkaewwattana, et al.. (2022). Comparison of the immunogenicity of ChAdOx1 nCoV-19 vaccine against the wild-type and delta variants in kidney transplant recipients and healthy volunteers. American Journal of Transplantation. 22(5). 1459–1466. 9 indexed citations
5.
Bruminhent, Jackrapong, Chavachol Setthaudom, Kumthorn Malathum, et al.. (2022). An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients: A randomized controlled trial (CVIM 4 study). American Journal of Transplantation. 22(11). 2651–2660. 6 indexed citations
6.
Pratumvinit, Busadee, et al.. (2022). External quality assessment scheme for HbA1c assays in Thailand: A 5-year experience. Practical Laboratory Medicine. 31. e00288–e00288. 2 indexed citations
7.
Bruminhent, Jackrapong, Chavachol Setthaudom, Sasisopin Kiertiburanakul, et al.. (2022). Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients. Scientific Reports. 12(1). 3587–3587. 16 indexed citations
8.
Setthaudom, Chavachol, Piyatida Chuengsaman, Arkom Nongnuch, et al.. (2022). Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3). Vaccines. 10(7). 1064–1064. 7 indexed citations
9.
Bruminhent, Jackrapong, Chavachol Setthaudom, Sasisopin Kiertiburanakul, et al.. (2021). SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study). American Journal of Transplantation. 22(3). 813–822. 22 indexed citations
10.
Leepiyasakulchai, Chaniya, Pintip Ngamjanyaporn, Ladawan Khowawisetsut, et al.. (2021). The expansion of activated naive DNA autoreactive B cells and its association with disease activity in systemic lupus erythematosus patients. Arthritis Research & Therapy. 23(1). 179–179. 20 indexed citations
11.
Chuengsaman, Piyatida, Chavachol Setthaudom, Arkom Nongnuch, et al.. (2021). Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine. Infectious Diseases and Therapy. 11(1). 351–365. 12 indexed citations
12.
Chanprapaph, Kumutnart, et al.. (2021). Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants. Frontiers in Medicine. 8. 769845–769845. 13 indexed citations
13.
Srichatrapimuk, Sirawat, Suwimon Manopwisedjaroen, Suppachok Kirdlarp, et al.. (2021). SARS‐CoV‐2 neutralizing antibodies decline over one year and patients with severe COVID‐19 pneumonia display a unique cytokine profile. International Journal of Infectious Diseases. 112. 227–234. 12 indexed citations
14.
Srichatrapimuk, Sirawat, Chavachol Setthaudom, Nopporn Apiwattanakul, Somnuek Sungkanuparph, & Angsana Phuphuakrat. (2021). Anti-HIV serological test algorithms to reduce false-positive and inconclusive results for low HIV prevalence and resource-limited areas. International Journal of STD & AIDS. 33(1). 63–72.
15.
Chotiprasitsakul, Darunee, et al.. (2020). Performance of real-time PCR and immunofluorescence assay for diagnosis of Pneumocystis pneumonia in real-world clinical practice. PLoS ONE. 15(12). e0244023–e0244023. 9 indexed citations
16.
17.
Ngamjanyaporn, Pintip, et al.. (2018). The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus. Scientific Reports. 8(1). 2620–2620. 33 indexed citations
18.
Kunakorn, Mongkol, et al.. (2017). National External Quality Assessment Scheme for HbA1c:Evaluation of Performance Using Assigned Values. 45(3). 1 indexed citations
19.
Setthaudom, Chavachol, et al.. (2011). Role of Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes on In Vitro Chloroquine Resistance in Isolates of Plasmodium falciparum from Thailand. American Journal of Tropical Medicine and Hygiene. 85(4). 606–611. 21 indexed citations
20.
Manuyakorn, Wiparat, et al.. (2007). Serum TGF-β1 in Allergic Asthma. Journal of Allergy and Clinical Immunology. 119(1). S85–S85. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Chavarot Breakdown of academic impact, for papers by Marcela Castro Breakdown of academic impact, for papers by Gerrit Ahrenstorf Breakdown of academic impact, for papers by Hamza Sakhi Breakdown of academic impact, for papers by Nassima Bellal Breakdown of academic impact, for papers by Noëlle Cognard Breakdown of academic impact, for papers by Jeremy Anderson Breakdown of academic impact, for papers by Eleonora Tartaglia Breakdown of academic impact, for papers by Michael Cartwright Breakdown of academic impact, for papers by Christophe Masset
Rankless by CCL
2026